Legionella Testing Market Size & Forecast By Application (Water Testing [Microbial Culture, DFA Stain, PCR, Others], IVD Testing [Blood Culture, Urine Antigen Test, DFA Stain, PCR, Others]), And Trend Analysis From 2013 To 2025

The global legionella testing market is expected to reach USD 352.6 million by 2025, according to a new study by Grand View Research Inc. The increasing prevalence of Legionella-related disorders, along with requirements of rapid diagnostic procedures, is expected to drive the industry growth.

According to CDC, the number of people suffering from Legionnaires’ disease was 4,548 in 2013. The incidence of pneumonia and related disorders is constantly rising due the contaminated environment. The rising incidence of Legionellosis will drive the market growth in the coming years, especially in the industrial sector.

The conventional bacterial testing is least preferred nowadays, since it is labor intensive and time consuming. Against the difficulties faced due to the conventional microbial testing methods, rapid automated tests are gaining popularity in the industry.

Further Key Findings From the Study Suggest:

Water testing has been identified as the largest testing type segment in terms of revenue, due to increased water testing activities in various industries as a preventive measure to control infections

Water testing has also been projected as fastest growing segment over the forecast period followed by IVD testing

Among the types of water testing applications, microbial culture held the majority of market share in 2015 in terms revenue

On the other hand, PCR is expected to be the fastest growing water testing type over the forecast period

Urine antigen tests were identified as the largest IVD testing segment, while PCR is projected to be the fastest growing segment

Key market players in Legionella testing market include Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Alere, Inc.; Roche Diagnostics; Thermo Fischer Scientific, Inc.; and Becton, Dickinson and Company (BD)

Table Of Contecnt

Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Legionella Testing Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Rising incidence of pneumonia and Legionella-related illnesses
3.1.1.2 Increasing demand for rapid advanced diagnostic techniques
3.1.1.3 Technological advancements in the field of bacterial testing
3.1.2 Market Restraint Analysis
3.1.2.1 Insufficient disposable income in developing and underdeveloped countries
3.1.2.2 Complex regulatory framework affects product approvals
3.2 Legionella testing - SWOT Analysis, By Factor (political & legal, economic and technological)
3.3 Industry Analysis - Porter’s
Chapter 4 Legionella Testing: Application Estimates & Trend Analysis
4.1 Legionella testing market: Application movement analysis
4.2 Water testing
4.2.1 Water testing market, 2013 - 2025 (USD Million)
4.2.2 Microbial culture
4.2.2.1 Microbial culture market, 2013 - 2025 (USD Million)
4.2.3 DFA stain
4.2.3.1 DFA Stain market, 2013 - 2025 (USD Million)
4.2.4 PCR
4.2.4.1 PCR market, 2013 - 2025 (USD Million)
4.2.5 Others
4.2.5.1 Others market, 2013 - 2025 (USD Million)
4.3 IVD testing
4.3.1 IVD testing Market, 2013 - 2025 (USD Million)
4.3.2 Blood Culture
4.3.2.1 Blood culture market, 2013 - 2025 (USD Million)
4.3.3 Urine Antigen Test
4.3.3.1 Urine antigen test market, 2013 - 2025 (USD Million)
4.3.4 DFA stain
4.3.4.1 DFA stain market, 2013 - 2025 (USD Million)
4.3.5 PCR
4.3.5.1 PCR market, 2013 - 2025 (USD Million)
4.3.6 Others
4.3.6.1 Others market, 2013 - 2025 (USD Million)
Chapter 5 Legionella Testing: Regional Estimates & Trend Analysis, by Product & Application
5.1 Legionella testing market share by region, 2013 & 2025
5.2 North America
5.2.1 North America Legionella testing market, 2013 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Legionella testing market, 2013 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Legionella testing market, 2013 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe Legionella testing market, 2013 - 2025 (USD Million)
5.3.2 Germany
5.3.2.1 Germany Legionella testing market, 2013 - 2025 (USD Million)
5.3.3 France
5.3.3.1 France Legionella testing market, 2013 - 2025 (USD Million)
5.3.4 Italy
5.3.4.1 Italy Legionella testing market, 2013 - 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Legionella testing market, 2013 - 2025 (USD Million)
5.4.2 Japan
5.4.2.1 Japan Legionella testing market, 2013 - 2025 (USD Million)
5.4.3 China
5.4.3.1 China Legionella testing market, 2013 - 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America Legionella testing market, 2013 - 2025 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Legionella testing market, 2013 - 2025 (USD Million)
5.6 MEA
5.6.1 MEA Legionella testing market, 2013 - 2025 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Legionella testing market, 2013 - 2025 (USD million)
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.3 Company Profiles
6.3.1 Alere, Inc.
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Beckman Coulter, Inc.
6.3.2.1 Company overview
6.3.2.2 Product benchmarking
6.3.2.3 Strategic initiatives
6.3.3 Becton, Dickinson and Company (BD)
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Bio-Rad Laboratories, Inc.
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 bioMerieux S.A.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.5.1.1 Strategic initiatives
6.5.6 Eiken Chemical Co., Ltd
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.7 Hologic, Inc.
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.8 Pro-lab Diagnostics, Inc.
6.5.8.1 Company overview
6.5.8.2 Product benchmarking
6.5.9 QIAGEN
6.5.9.1 Company overview
6.5.9.2 Financial performance
6.5.9.3 Product benchmarking
6.5.10 Roche Diagnostics
6.5.10.1 Company overview
6.5.10.2 Product benchmarking
6.5.10.3 Strategic initiatives
6.5.11 Takara Bio, Inc.
6.5.11.1 Company overview
6.5.11.2 Financial performance
6.5.11.3 Product benchmarking
6.5.11.4 Strategic initiatives
6.5.12 Thermo Fischer Scientific, Inc.
6.5.12.1 Company overview
6.5.12.2 Financial performance
6.5.12.3 Product benchmarking
6.5.12.4 Strategic initiatives